'Latam adalimumab' presentation slideshows

LATAM Adalimumab Market - Industry Analysis, Trends and Forecast 2015 - 2023

This report on LATAM Adalimumab market analyzes the current and future prospects of the adalimumab sales pertaining to Latin American countries. The stakeholders of this report include companies engaged in production and commercialization of adalimumab biosimilars across the globe. The LATAM adalimumab market was valued at US$994.8 mn in 2014 and is expected to reach US$1,186.4 mn by 2023, at a CAGR of 0.4% during the forecast period from 2015 to 2023. Read Full Report: http://www.transparencymarketresearch.com/latam-adalimumab-market.html

192 views • 6 slides